H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 32 (3) , 435-445
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade GliomasCancer Cell, 2013
- Transcriptional regulation by Polycomb group proteinsNature Structural & Molecular Biology, 2013
- Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcomaNature Genetics, 2013
- Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric GlioblastomaScience, 2013
- Clinical outcome for patients with dedifferentiated chondrosarcoma: a report of 9 cases at a single instituteJournal of Orthopaedic Surgery and Research, 2012
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursThe Journal of Pathology, 2011
- Dedifferentiated chondrosarcoma: Prognostic factors and outcome from a European groupEuropean Journal of Cancer, 2007
- Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 casesJournal of Cancer Research and Clinical Oncology, 2007
- Dedifferentiated central chondrosarcomaCancer, 2006
- H-ras Oncogene Mutation in Dedifferentiated Chondrosarcoma: Polymerase Chain Reaction-Restriction Fragment Length Polymorphism AnalysisLaboratory Investigation, 2001